Chemed Company Profile (NYSE:CHE)

About Chemed (NYSE:CHE)

Chemed logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:CHE
  • CUSIP: 16359R10
  • Web:
  • Market Cap: $3.26 billion
  • Outstanding Shares: 16,082,000
Average Prices:
  • 50 Day Moving Avg: $196.05
  • 200 Day Moving Avg: $174.14
  • 52 Week Range: $126.54 - $216.01
  • Trailing P/E Ratio: 29.78
  • Foreward P/E Ratio: 23.96
  • P/E Growth: 2.54
Sales & Book Value:
  • Annual Revenue: $1.59 billion
  • Price / Sales: 2.05
  • Book Value: $31.13 per share
  • Price / Book: 6.52
  • Annual Dividend: $1.04
  • Dividend Yield: 0.5%
  • EBIDTA: $217.5 million
  • Net Margins: 6.77%
  • Return on Equity: 23.95%
  • Return on Assets: 13.59%
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 0.79%
  • Quick Ratio: 0.76%
  • Average Volume: 90,098 shs.
  • Beta: 1.21
  • Short Ratio: 19.23

Frequently Asked Questions for Chemed (NYSE:CHE)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Monday, May 15th. Stockholders of record on Thursday, May 25th will be given a dividend of $0.26 per share on Wednesday, June 14th. This represents a $1.04 annualized dividend and a dividend yield of 0.51%. The ex-dividend date of this dividend is Tuesday, May 23rd. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its board has authorized a share buyback program on Monday, April 10th 2017, which allows the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy up to 3.3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company's management believes its shares are undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) released its quarterly earnings results on Wednesday, April, 26th. The company reported $1.82 earnings per share for the quarter, topping analysts' consensus estimates of $1.78 by $0.04. The firm earned $405.90 million during the quarter, compared to analyst estimates of $399.75 million. Chemed had a return on equity of 23.95% and a net margin of 6.77%. The firm's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.62 earnings per share. View Chemed's Earnings History.

When will Chemed make its next earnings announcement?

Chemed is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for Chemed.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share (EPS) guidance of $7.80-$8.00 for the period, compared to the Thomson Reuters consensus estimate of $7.90.

Where is Chemed's stock going? Where will Chemed's stock price be in 2017?

3 equities research analysts have issued twelve-month price objectives for Chemed's shares. Their forecasts range from $148.00 to $155.00. On average, they anticipate Chemed's share price to reach $151.50 in the next year. View Analyst Ratings for Chemed.

Who are some of Chemed's key competitors?

Who are Chemed's key executives?

Chemed's management team includes the folowing people:

  • George J. Walsh III, Independent Chairman of the Board
  • Kevin J. McNamara, President, Chief Executive Officer, Director
  • David Patrick Williams, Chief Financial Officer, Executive Vice President
  • Spencer S. Lee, Executive Vice President
  • Nicholas Michael Westfall, Executive Vice President
  • Michael D. Witzeman, Principal Accounting Officer, Controller
  • Thomas Charles Hutton, Director
  • Joel F. Gemunder, Independent Director
  • Patrick P. Grace, Independent Director
  • Walter L. Krebs, Independent Director

Who owns Chemed stock?

Chemed's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.16%), Vanguard Group Inc. (11.17%), Neuberger Berman Group LLC (6.59%), FMR LLC (5.08%), Riverbridge Partners LLC (4.52%) and Gamco Investors INC. ET AL (3.66%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.

Who sold Chemed stock? Who is selling Chemed stock?

Chemed's stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Bank of New York Mellon Corp, Ameriprise Financial Inc., FMR LLC, Rockefeller Financial Services Inc., Gabelli Funds LLC, Renaissance Technologies LLC and Gamco Investors INC. ET AL. Company insiders that have sold Chemed stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.

Who bought Chemed stock? Who is buying Chemed stock?

Chemed's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., State Street Corp, Oppenheimer Asset Management Inc., Neuberger Berman Group LLC, Bank of America Corp DE, Seizert Capital Partners LLC and Karp Capital Management Corp. View Insider Buying and Selling for Chemed.

How do I buy Chemed stock?

Shares of Chemed can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of Chemed stock can currently be purchased for approximately $202.98.

MarketBeat Community Rating for Chemed (NYSE CHE)
Community Ranking:  2.0 out of 5 ( )
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  153
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Chemed (NYSE:CHE) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $151.50 (25.36% downside)

Analysts' Ratings History for Chemed (NYSE:CHE)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/1/2016Royal Bank of CanadaReiterated RatingSector Perform$162.00 -> $148.00N/AView Rating Details
9/27/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$155.00N/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
9/15/2015Deutsche Bank AGReiterated RatingBuyN/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Chemed (NYSE:CHE)
Earnings by Quarter for Chemed (NYSE:CHE)
Earnings History by Quarter for Chemed (NYSE:CHE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Chemed (NYSE:CHE)
2017 EPS Consensus Estimate: $7.93
2018 EPS Consensus Estimate: $8.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20171$1.96$1.96$1.96
Q4 20171$2.31$2.31$2.31
Q1 20181$1.92$1.92$1.92
Q2 20181$2.03$2.03$2.03
Q3 20181$2.10$2.10$2.10
Q4 20181$2.44$2.44$2.44
(Data provided by Zacks Investment Research)


Current Dividend Information for Chemed (NYSE:CHE)
Next Dividend:6/14/2017
Annual Dividend:$1.04
Dividend Yield:0.51%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:16.59% (Trailing 12 Months of Earnings)
13.08% (Based on This Year's Estimates)
12.28% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Chemed (NYSE:CHE)

Dividend History by Quarter for Chemed (NYSE:CHE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Chemed (NYSE:CHE)
Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 99.72%
Insider Trades by Quarter for Chemed (NYSE:CHE)
Institutional Ownership by Quarter for Chemed (NYSE:CHE)
Insider Trades by Quarter for Chemed (NYSE:CHE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.46View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.00View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.00View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.00View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.38View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Chemed (NYSE:CHE)
Latest Headlines for Chemed (NYSE:CHE)
DateHeadline logoChemed Co. (che) to Issue $0.26 Quarterly Dividend - May 16 at 10:22 AM logoChemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend - May 15 at 4:01 PM logoChemed Corporation to Present at the Bank of America Merrill Lynch 2017 Health Care Conference - May 11 at 4:54 PM logoInsider Buying: Chemed Co. (CHE) Director Acquires 94 Shares of Stock - May 5 at 5:14 PM logoChemed Co. (CHE) Director Sells $81,940.00 in Stock - May 5 at 4:51 PM logoFavorable News Coverage Unlikely to Affect Chemed (CHE) Share Price - May 4 at 5:14 PM logoChemed Co. (CHE) Insider Sells $820,440.00 in Stock - May 2 at 6:46 PM logoSpencer S. Lee Sells 1,000 Shares of Chemed Co. (CHE) Stock - May 1 at 8:24 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 - May 1 at 4:14 PM logoOppenheimer Holdings Weighs in on Chemed Co.'s Q3 2018 Earnings (CHE) - May 1 at 1:04 PM logoFavorable Press Coverage Somewhat Unlikely to Affect Chemed (CHE) Stock Price - April 29 at 5:47 PM logoEdited Transcript of CHE earnings conference call or presentation 27-Apr-17 2:00pm GMT - April 28 at 5:14 PM logoChemed Reports First-Quarter 2017 Results - April 27 at 4:43 PM logoChemed Co. (CHE) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - April 27 at 12:20 AM logoChemed Co. (CHE) Announces Earnings Results - April 26 at 11:24 PM logoChemed (CHE) Earns Daily News Sentiment Score of 0.34 - April 26 at 9:00 PM logoChemed Co. (CHE) Releases FY17 Earnings Guidance - April 26 at 6:49 PM logoChemed posts 1Q profit - April 26 at 6:28 PM logoChemed (CHE) Given Daily News Impact Rating of 0.31 - April 20 at 4:11 PM logoEXCLUSIVE: How Facebook fueled the Courier's stock contest leader - April 17 at 4:06 PM logoChemed (CHE) Earning Somewhat Critical News Coverage, Study Finds - April 17 at 2:54 PM logoChemed (CHE) Earns Media Impact Score of 0.50 - April 14 at 9:21 AM logoChemed (CHE) Board of Directors Initiates Share Buyback Plan - April 10 at 9:14 AM logoChemed To Report First-Quarter 2017 Earnings April 26, Related Conference Call To Be Held On April 27 - April 7 at 8:58 AM logoCHEMED CORP Files SEC form 8-K, Change in Directors or Principal Officers - April 3 at 4:40 PM logoChemed (CHE) Up 6.4% Since Earnings Report: Can It Continue? - March 21 at 8:01 AM logoChemed Corporation to Present at the Oppenheimer 27th Annual Healthcare Conference - March 15 at 4:38 PM logo8:30 am Chemed's Board authorizes an additional $100 million for stock repurchase under its existing share repurchase program - March 13 at 12:43 PM logoChemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase - March 13 at 12:43 PM logoCHEMED CORP Files SEC form 8-K, Other Events - March 13 at 12:43 PM logoCHEMED CORP Financials - March 3 at 4:17 PM logoCHEMED CORP Files SEC form 10-K, Annual Report - February 27 at 2:49 PM logoEdited Transcript of CHE earnings conference call or presentation 16-Feb-17 3:00pm GMT - February 17 at 5:56 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017 - February 17 at 5:56 PM logoCHEMED CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year - February 17 at 5:56 PM logoChemed Corporation (CHE) Reports In-Line Q4 EPS - February 16 at 4:22 PM logoChemed Corp. Profit Climbs 2% In Q4 - February 16 at 4:22 PM logoChemed's (CHE) CEO Kevin McNamara on Q4 2016 Results - Earnings Call Transcript - February 16 at 4:22 PM logoBRIEF-Chemed Q4 GAAP earnings per share $1.94 - February 16 at 4:22 PM logoChemed Corp Earnings Call scheduled for 10:00 am ET today - February 16 at 4:22 PM logoChemed Corporation to Present at the 2017 RBC Capital Markets’ Global Healthcare Conference - February 16 at 4:22 PM logoQ4 2016 Chemed Corp Earnings Release - After Market Close - February 16 at 9:55 AM logoChemed Reports Fourth-Quarter 2016 Results - February 16 at 9:55 AM logo4:19 pm Chemed beats by $0.03, misses on revs; guides FY17 EPS above consensus - February 16 at 9:55 AM logoCHEMED CORP Files SEC form 8-K, Results of Operations and Financial Condition - February 16 at 9:55 AM logoChemed posts 4Q profit - February 16 at 9:55 AM logoChemed To Report Fourth-Quarter 2016 Earnings February 15, Related Conference Call To Be Held On February 16 - January 20 at 5:25 PM logoEx-Dividend Reminder: Eli Lilly, Teleflex and Chemed - November 9 at 12:06 PM logoChemed Corporation to Present at the 2016 Credit Suisse Healthcare Conference - November 1 at 4:16 PM logoCHEMED CORP Files SEC form 10-Q, Quarterly Report - November 1 at 8:20 AM



Chemed (CHE) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by Staff